GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
541
c/glp1eu·posted 8 months ago by u/nl_verzekering

[Discussion] we are measuring EU at the wrong time and calling it noise

Discussion Clean Column ×1

Thinking out loud about this: we are measuring EU at the wrong time and calling it noise.

Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.

Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.

Compared prices across two neighbouring countries and found the difference was mostly pack size once I normalised it.

That is everything I have. The rest is opinion and I have tried to keep it out.

4,563 up / 4,022 down53% upvoted21 commentsid 10q1uj21 Nov 2025

21 comments

21 in this archive, depth 6

best — the order this archive was captured in

u/nordic_pricingMOD44 points·8 months ago

Pointing this one at a pharmacist locally. Eligibility questions have national answers we cannot give.

replysharereportpermalink
u/nl_verzekeringOP24 points·8 months ago

Is the prescription from the same country as the pharmacy?

replysharereportpermalink
u/fabio_ibarra7 points·8 months ago

reimbursement is national, not European, and that is the whole board

replysharereportpermalink
[removed]5 points·8 months ago

[removed by moderator]

replysharereportpermalink
u/marit_mwangi2 points·8 months ago

say which country or the thread is useless

replysharereportpermalink
u/erez_yilmaz1 point·8 months ago·edited

Careful, that guidance is from a different country and this thread is asking about somewhere else entirely.

replysharereportpermalink
u/dose_diary_danalog keeper30 points·8 months ago

Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.

replysharereportpermalink
u/nayeli_fonseca9 points·8 months ago

Agreed — authorisation is European, reimbursement is national, and almost every confused thread here misses that split.

replysharereportpermalink
u/dario_bakken8 points·8 months ago

Are you comparing the same presentation, or different pack sizes?

replysharereportpermalink
u/marisol_frisk16 points·8 months ago

Right, and a shortage notice in one country tells you very little about the next one along.

replysharereportpermalink
u/cesar_oyelaran5 points·8 months ago

Correction: that is the authorisation position, and the question was about reimbursement. Different bodies, different answers.

replysharereportpermalink
u/oskar_malinowski15 points·8 months ago

A supply notice in one member state made the front page here and had no effect at all where I am.

replysharereportpermalink
u/sten_palacios18 points·8 months ago

Not convinced — cross-border prescription recognition is narrower than you are describing and the exceptions matter.

replysharereportpermalink
load more comments (1) →
u/solene_ilunga7 points·8 months ago

This. The published reimbursement criteria are the document to read, and most member states do publish them.

replysharereportpermalink
u/ewan_tulloch10 points·8 months ago

Read the published reimbursement criteria where I live rather than asking. Took twenty minutes and answered everything.

replysharereportpermalink
u/nordic_pricing7 points·8 months ago

the language barrier is a real cost and nobody budgets for it

replysharereportpermalink
u/zaid_eriksen2 points·8 months ago

That shortage notice was national and does not apply where the question is coming from.

replysharereportpermalink
u/nl_verzekeringOP1 point·8 months ago

Correcting myself upthread: the criterion I quoted was updated for this year.

replysharereportpermalink
u/osman_brandt3 points·8 months ago

Yes — keep both the prescription and the receipt. Claims processes ask for both and never at a convenient moment.

replysharereportpermalink
u/kaplan_meier_kim2 points·8 months ago

a shortage in one member state is not a shortage in all of them

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.